Assessing and Charting the Future Path : Addressing the Decline of Brain Tumor Specialists in Korea - Insights from the Korean Brain Tumor Society (KBTS) Future Strategy Committee of 2023
- Author:
Joonho BYUN
1
;
Kyeong-O GO
;
Kyung-Min KIM
;
Dong-Won SHIN
;
Jihwan YOO
;
Yeo Song KIM
;
Sae Min KWON
;
Young Zoon KIM
;
Seon-Hwan KIM
Author Information
- Publication Type:Clinical Article
- From:Journal of Korean Neurosurgical Society 2025;68(1):97-104
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objective:: Although Republic of Korea is an advanced country in medical technology with a successful treatment rate for serious diseases, such as cancer, and has improved technology for highly difficult surgery, many excellent medical doctors and physicians are struggling due to the recent unreasonable medical environment. Specialization in brain tumor surgery also faces challenges in Republic of Korea, including low financial incentives, legal threats, and limited career prospects. In response, the Korean Brain Tumor Society (KBTS) formed the Future Strategy Committee to assess these obstacles and propose solutions.
Methods:: A survey was conducted among the KBTS members to understand their perceptions and concerns across different career stages.
Results:: The findings revealed a decline in interest among chief residents in brain tumor surgery, owing to limited job opportunities and income prospects. Neurosurgical fellows expressed neutral satisfaction but highlighted challenges, such as low patient numbers and income. Faculty members with varying levels of experience echoed similar concerns, emphasizing the need for improved financial incentives and job stability. Despite these challenges, the respondents expressed dedication to the field and suggested strategies for improvement.
Conclusion:: The KBTS outlines a vision that focuses on practical excellence, comprehensive research, professional education, responsibilities, and member satisfaction. Addressing these challenges requires collaborative efforts among healthcare institutions, professional societies, and policymakers to support brain tumor specialists and enhance patient care.
